Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Peripheral T-Cell Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04541017
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Who this might be right for
Mycosis FungoidesRecurrent Mycosis FungoidesRecurrent Mycosis Fungoides and Sezary Syndrome+9 more
National Cancer Institute (NCI) 8
Early research (Phase 1)UnknownNCT05387226
What this trial is testing

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
T-cell LymphomaVirusIntravenous Injection
The First Affiliated Hospital of Bengbu Medical University 6
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Testing effectiveness (Phase 2)Study completedNCT00787761
What this trial is testing

Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

Who this might be right for
Myeloproliferative DisordersKidney CancerLeukemia+4 more
Northside Hospital, Inc. 24
Early research (Phase 1)UnknownNCT05900089
What this trial is testing

Efficacy and Safety of SHR0302 in Patients With Relapsed/Refractory Peripheral T/NK Cell Lymphoma

Who this might be right for
Peripheral T Cell Lymphoma
Henan Cancer Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00959686
What this trial is testing

Bendamustine in Patients With Refractory or Relapsed T-cell Lymphoma

Who this might be right for
T-cell Lymphoma
French Innovative Leukemia Organisation 45
Early research (Phase 1)Ended earlyNCT05403450
What this trial is testing

Tolinapant in Combination With Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma (R/R PTCL)

Who this might be right for
Relapsed/Refractory Peripheral T-cell Lymphoma
Taiho Oncology, Inc. 33
Early research (Phase 1)Active Not RecruitingNCT03602157
What this trial is testing

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

Who this might be right for
LymphomaImmune System DiseasesImmunoproliferative Disorders+10 more
UNC Lineberger Comprehensive Cancer Center 43
Early research (Phase 1)Study completedNCT00771472
What this trial is testing

Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1)

Who this might be right for
Lymphoma
Merck Sharp & Dohme LLC 10
Not applicableStudy completedNCT00060021
What this trial is testing

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

Who this might be right for
Cancer
National Cancer Institute (NCI)
Not applicableStudy completedNCT00376922
What this trial is testing

Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+7 more
Wake Forest University Health Sciences 65
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07279584
What this trial is testing

Golidocitinib Combined With GemOx in RR PTCL

Who this might be right for
Peripheral T-cell Lymphomas (PTCL)
Ruijin Hospital 31
Testing effectiveness (Phase 2)Ended earlyNCT01419795
What this trial is testing

Lenalidomide With or Without Rituximab in Treating Patients With Progressive or Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Prolymphocytic Leukemia, or Non-Hodgkin Lymphoma Previously Treated With Donor Stem Cell Transplant

Who this might be right for
Adult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell Lymphoma+31 more
Fred Hutchinson Cancer Center 3
Testing effectiveness (Phase 2)Looking for participantsNCT06378190
What this trial is testing

Treatment of Relapsed or Refractory B-cell Lymphoma With Chimeric Antigen Receptor (CAR) T-cell Therapy Produced by a New Technology

Who this might be right for
Refractory B-Cell LymphomaB-cell Lymphoma Recurrent
Instituto de Investigación Biomédica de Salamanca 27
Testing effectiveness (Phase 2)Looking for participantsNCT06534060
What this trial is testing

MB-105 in Patients With CD5 Positive T-cell Lymphoma

Who this might be right for
Lymphoma, T-Cell
March Biosciences Inc 46
Early research (Phase 1)Study completedNCT01902225
What this trial is testing

Phase I Dose-finding and Preliminary Efficacy Study of the Istodax® in Combination With Doxil® for the Treatment of Adults With Relapsed or Refractory Cutaneous T-cell Lymphoma

Who this might be right for
LymphomaT-Cell LymphomaCutaneous Lymphoma
Weiyun Ai 24
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Testing effectiveness (Phase 2)WithdrawnNCT01101412
What this trial is testing

Antimicrobial Solution or Saline Solution in Maintaining Catheter Patency and Preventing Catheter-Related Blood Infections in Patients With Malignancies

Who this might be right for
Chronic Myeloproliferative DisordersInfectionLeukemia+6 more
M.D. Anderson Cancer Center
Early research (Phase 1)Looking for participantsNCT06914037
What this trial is testing

A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies

Who this might be right for
Peripheral T-cell LymphomaCutaneous T-cell Lymphoma (CTCL)NHL (Non-Hodgkin Lymphoma)
Tianjin Medical University Cancer Institute and Hospital 24
Testing effectiveness (Phase 2)Study completedNCT02588651
What this trial is testing

A Phase II Study of Single Agent Brentuximab Vedotin in Relapsed/Refractory CD30 Low (<10%) Mature T Cell Lymphoma (TCL)

Who this might be right for
T-cell LymphomaAngioimmunoblastic T-cell LymphomaHepato-splenic T-cell Lymphoma+3 more
Deepa Jagadeesh 23
Next Page